Home / Streptavidin / Streptavidin-HRP

Streptavidin-HRP

DY998 62 Citations 13 Reviews Datasheet / COA / SDS
Set of 5 vials enough for 75 plates total
Catalog # Availability Size / Price Qty
DY998
Streptavidin-HRP
1 Image
Product Details
Citations (62)
FAQs
Supplemental Products
Reviews (13)
Summary Product Datasheets Data Images

Streptavidin-HRP Summary

INTENDED USE & DESCRIPTION

Streptavidin-HRP (Part # 890803) contains 5 vials (1 mL/vial) of streptavidin conjugated to horseradish peroxidase for use with biotinylated detection antibodies in ELISAs and Western Blotting.

STORAGE & STABILITY

Store unopened at 2-8 °C. Stable for up to 6 months after opening when stored at 2-8 °C. Do Not Freeze.

REAGENT PREPARATION

For use in ELISAs, dilute to the working concentration specified on the vial label using 1% BSA/PBS or Reagent Diluent Concentrate 2 (Catalog # DY995) diluted 1:10 in deionized water. For use in Western blots, the suggested dilution is 1:200-1:2000 in an appropriate diluent. Use the diluted reagent within 60 minutes. 

Specifications

Shipping Conditions
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Applications
ELISA

Product Datasheets

Product Datasheet
COA
SDS

Data Example

Streptavidin-HRP View Larger

Streptavidin-HRP

Reagents Provided

Citations for Streptavidin-HRP

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

62 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. New Paradigms to Assess Consequences of Long-Term, Low-Dose Curcumin Exposure in Lung Cancer Cells
    Authors: G Smagurausk, J Mahale, K Brown, AL Thomas, LM Howells
    Molecules, 2020;25(2):.  2020
  2. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
    Authors: D Karpova, MP Rettig, J Ritchey, D Cancilla, S Christ, L Gehrs, E Chendamara, MO Evbuomwan, M Holt, J Zhang, G Abou-Ezzi, H Celik, E Wiercinska, W Yang, F Gao, LG Eissenberg, RF Heier, SD Arnett, MJ Meyers, MJ Prinsen, DW Griggs, A Trumpp, PG Ruminski, DM Morrow, HB Bonig, DC Link, JF DiPersio
    J. Clin. Invest., 2019;129(7):2745-2759.  2019
  3. A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation
    Authors: XN Zhang, Q Cheng, J Chen, AT Lam, Y Lu, Z Dai, H Pei, NM Evdokimov, SG Louie, Y Zhang
    Nat Commun, 2019;10(1):4196.  2019
  4. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
    Authors: J Russick, S Delignat, P Milanov, O Christophe, G Boros, CV Denis, PJ Lenting, SV Kaveri, S Lacroix-De
    Haematologica, 2019;0(0):.  2019
  5. Cecropia obtusa extract and chlorogenic acid exhibit anti aging effect in human fibroblasts and keratinocytes cells exposed to UV radiation
    Authors: GAD Alves, R Oliveira d, HL Ghislain R, H Masaki, MJV Fonseca
    PLoS ONE, 2019;14(5):e0216501.  2019
  6. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage
    Authors: CH Chao, WC Wu, YC Lai, PJ Tsai, GC Perng, YS Lin, TM Yeh
    PLoS Pathog., 2019;15(4):e1007625.  2019
  7. Engineering of CHO cells for the production of vertebrate recombinant sialyltransferases
    Authors: B Houeix, MT Cairns
    PeerJ, 2019;7(0):e5788.  2019
  8. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival
    Authors: JYC Yang, SE Verleden, A Zarinsefat, BM Vanaudenae, R Vos, GM Verleden, RD Sarwal, TK Sigdel, JM Liberto, I Damm, D Watson, MM Sarwal
    J Clin Med, 2019;8(2):.  2019
  9. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
    Authors: YL Lin, YH Chow, LM Huang, SM Hsieh, PY Cheng, KC Hu, BL Chiang
    Sci Rep, 2018;8(1):10713.  2018
  10. Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
    Authors: SM Chin, CR Kimberlin, Z Roe-Zurz, P Zhang, A Xu, S Liao-Chan, D Sen, AR Nager, NS Oakdale, C Brown, F Wang, Y Yang, K Lindquist, YA Yeung, S Salek-Arda, J Chaparro-R
    Nat Commun, 2018;9(1):4679.  2018
  11. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women
    Authors: C Engdahl, A Bondt, U Harre, J Raufer, R Pfeifle, A Camponesch, M Wuhrer, M Seeling, IL Mårtensson, F Nimmerjahn, G Krönke, HU Scherer, H Forsblad-d, G Schett
    Arthritis Res. Ther., 2018;20(1):84.  2018
  12. Impact of immunization against OxLDL on the pulmonary response to cigarette smoke exposure in mice
    Authors: M Talbot, M Hamel-Auge, MJ Beaulieu, M Gazzola, A Lechasseur, S Aubin, MÈ Paré, D Marsolais, Y Bossé, MC Morissette
    Respir. Res., 2018;19(1):131.  2018
  13. A systematic analysis of VRC01 antibody expression in Pichia pastoris through signal peptide optimization
    Authors: R Aw, PF McKay, RJ Shattock, KM Polizzi
    Protein Expr. Purif., 2018;0(0):.  2018
  14. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection
    Authors: MC Patel, LM Pletneva, MS Boukhvalov, SN Vogel, AE Kajon, JCG Blanco
    Front Microbiol, 2017;8(0):1646.  2017
  15. A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
    Authors: DI Bromage, S Taferner, M Pillai, DM Yellon, SM Davidson
    PLoS ONE, 2017;12(4):e0174447.  2017
  16. Inhibitory Effects of Polyacetylene Compounds from Panax ginseng on Neurotrophin Receptor-Mediated Hair Growth
    Authors: A Suzuki, D Matsuura, H Kanatani, S Yano, M Tsunakawa, S Matsuyama, H Shigemori
    Biol. Pharm. Bull., 2017;40(10):1784-1788.  2017
  17. Hydrogels with precisely controlled integrin activation dictate vascular patterning and�permeability
    Authors: S Li, LR Nih, H Bachman, P Fei, Y Li, E Nam, R Dimatteo, ST Carmichael, TH Barker, T Segura
    Nat Mater, 2017;16(9):953-961.  2017
  18. Vitronectin as a Micromanager of Cell Response in Material-Driven Fibronectin Nanonetworks
    Authors: M Cantini, K Gomide, V Moulisova, C González-G, M Salmerón-S
    Adv Biosyst, 2017;1(9):1700047.  2017
  19. Inhibition of DNA replication by an anti-PCNA aptamer/PCNA complex
    Authors: E Kowalska, F Bartnicki, R Fujisawa, P Bonarek, P Hermanowic, T Tsurimoto, K Muszynska, W Strzalka
    Nucleic Acids Res., 2017;0(0):.  2017
  20. Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction
    Authors: JR Wodicka, AM Chambers, GS Sangha, CJ Goergen, A Panitch
    Pharmaceuticals (Basel), 2017;10(2):.  2017
  21. Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages
    Authors: F Oddone, G Roberti, A Micera, A Busanello, S Bonini, L Quaranta, L Agnifili, G Manni
    PLoS ONE, 2017;12(1):e0168565.  2017
  22. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia
    PLoS ONE, 2016;11(11):e0164953.  2016
  23. TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    Authors: McKay P, King D, Mann J, Barinaga G, Carter D, Shattock R
    PLoS ONE, 2016;11(2):e0148984.  2016
  24. Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction
    Authors: Tom J Parry
    Eur. J. Pharmacol, 2016;796(0):76-89.  2016
  25. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge
    PLoS ONE, 2016;11(8):e0161169.  2016
  26. A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1
    Genes Dev, 2016;30(9):1070-85.  2016
  27. Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis
    PLoS ONE, 2016;11(8):e0161465.  2016
  28. Impact of Histone H1 on the Progression of Allergic Rhinitis and Its Suppression by Neutralizing Antibody in Mice
    Authors: T Nakano, R Kamei, T Fujimura, Y Takaoka, A Hori, CY Lai, KC Chiang, Y Shimada, N Ohmori, T Goto, K Ono, CL Chen, S Goto, S Kawamoto
    PLoS ONE, 2016;11(4):e0153630.  2016
  29. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
    Authors: Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier R
    J Neuroinflammation, 2015;12(0):119.  2015
  30. Dendritic cells induce Th2-mediated airway inflammatory responses to house dust mite via DNA-dependent protein kinase.
    Authors: Mishra, Amarjit, Brown, Alexandr, Yao, Xianglan, Yang, Shutong, Park, Sung-Jun, Liu, Chengyu, Dagur, Pradeep, McCoy, J Philip, Keeran, Karen J, Nugent, Gayle Z, Jeffries, Kenneth, Qu, Xuan, Yu, Zu-Xi, Levine, Stewart, Chung, Jay H
    Nat Commun, 2015;6(0):6224.  2015
  31. Upregulated interleukin-21 receptor on B cells associated with the downregulation of IgE in patients with allergic rhinitis.
    Authors: Jen, Hsiao-Yu, Yang, Yao-Hsu, Chiang, Bor-Luen, Chuang, Ya-Hui
    J Interferon Cytokine Res, 2015;35(1):42-8.  2015
  32. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
    Authors: Costa-Pereira C, Moreira M, Soares R, Marteleto B, Ribeiro V, Franca-Dias M, Cardoso L, Viana K, Giunchetti R, Martins-Filho O, Araujo M
    BMC Vet Res, 2015;11(0):92.  2015
  33. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
    Authors: Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, Liu K, Chen Y, Jiang M
    J Transl Med, 2015;13(0):191.  2015
  34. Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma.
    Authors: Hengartner N, Fiedler J, Schrezenmeier H, Huber-Lang M, Brenner R
    PLoS ONE, 2015;10(1):e0116772.  2015
  35. The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.
    Authors: Yates, Sharon C, Zafar, Amen, Rabai, Erzsebet, Foxall, James B, Nagy, Sheila, Morrison, Karen E, Clarke, Carl, Esiri, Margaret, Christie, Sharon, Smith, A David, Nagy, Zsuzsann
    PLoS ONE, 2015;10(1):e0114050.  2015
  36. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
    Authors: Frehn L, Jansen A, Bennek E, Mandic A, Temizel I, Tischendorf S, Verdier J, Tacke F, Streetz K, Trautwein C, Sellge G
    PLoS ONE, 2014;9(9):e106750.  2014
  37. Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
    Authors: McKay P, Cope A, Mann J, Joseph S, Esteban M, Tatoud R, Carter D, Reed S, Weber J, Shattock R
    PLoS ONE, 2014;9(1):e84707.  2014
  38. Genome-wide identification and quantification of protein synthesis in cultured cells and whole tissues by puromycin-associated nascent chain proteomics (PUNCH-P).
    Authors: Aviner, Ranen, Geiger, Tamar, Elroy-Stein, Orna
    Nat Protoc, 2014;9(4):751-60.  2014
  39. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
    Authors: Rossi O, Pesce I, Giannelli C, Aprea S, Caboni M, Citiulo F, Valentini S, Ferlenghi I, MacLennan C, D'Oro U, Saul A, Gerke C
    J Biol Chem, 2014;289(36):24922-35.  2014
  40. Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.
    Authors: Moelants, Eva A V, Loozen, Gitte, Mortier, Anneleen, Martens, Erik, Opdenakker, Ghislain, Mizgalska, Danuta, Szmigielski, Borys, Potempa, Jan, Van Damme, Jo, Teughels, Wim, Proost, Paul
    Infect Immun, 2014;82(6):2511-9.  2014
  41. Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression.
    Authors: Franzoni G, Kurkure N, Essler S, Pedrera M, Everett H, Bodman-Smith K, Crooke H, Graham S
    PLoS ONE, 2013;8(12):e84246.  2013
  42. A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice.
    Authors: Tregoning, John S, Buffa, Viviana, Oszmiana, Anna, Klein, Katja, Walters, Adam A, Shattock, Robin J
    PLoS ONE, 2013;8(11):e80559.  2013
  43. Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.
    Authors: Winckelmann A, Munk-Petersen L, Rasmussen T, Melchjorsen J, Hjelholt T, Montefiori D, Ostergaard L, Sogaard O, Tolstrup M
    PLoS ONE, 2013;8(4):e62074.  2013
  44. A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys.
    Authors: Ohshima-Hosoyama S, Simmons HA, Goecks N
    PLoS ONE, 2012;7(6):e39036.  2012
  45. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells.
    Authors: Notley CA, Brown MA, Wright GP, Ehrenstein MR
    J. Immunol., 2011;186(8):4967-72.  2011
  46. Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.
    Authors: King GD, Muhammad AK, Larocque D
    Mol. Ther., 2011;19(10):1793-801.  2011
  47. IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression.
    Authors: Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE
    J. Immunol., 2011;186(4):2613-22.  2011
  48. Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
    Authors: Meyer-Siegler KL, Cox J, Leng L, Bucala R, Vera PL
    Cancer Lett., 2010;290(1):49-57.  2010
  49. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
    Authors: Iaci JF, Ganguly A, Finklestein SP, Parry TJ, Ren J, Saha S, Sietsma DK, Srinivas M, Vecchione AM, Caggiano AO
    Neuropharmacology, 2010;59(7):640-9.  2010
  50. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.
    Authors: Iversen MB, Ank N, Melchjorsen J, Paludan SR
    J. Virol., 2010;84(9):4579-86.  2010
  51. Oxidized alpha1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema.
    Authors: Li Z, Alam S, Wang J, Sandstrom CS, Janciauskiene S, Mahadeva R
    Am. J. Physiol. Lung Cell Mol. Physiol., 2009;297(2):L388-400.  2009
  52. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
    Authors: Mouawad R, Spano JP, Comperat E, Capron F, Khayat D
    Eur. J. Cancer, 2009;45(8):1407-14.  2009
  53. Nanobacteria are mineralo fetuin complexes.
    Authors: Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P, Campagna B, La Scola B, Mege JL, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P
    PLoS Pathog., 2008;4(2):e41.  2008
  54. Facilitated in vivo synthesis of ribonucleic acid and protein via T7 RNA polymerase.
    Authors: Wang TH, Yu SH, Au LC
    Anal. Biochem., 2008;375(1):97-104.  2008
  55. Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis.
    Authors: Kim JY, Kwok SK, Hur KH, Kim HJ, Kim NS, Yoo SA, Kim WU, Cho CS
    Clin. Exp. Immunol., 2008;152(2):328-35.  2008
  56. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity.
    Authors: Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ
    Immunity, 2007;26(4):445-59.  2007
  57. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
    Authors: Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J
    Blood, 2007;110(6):1748-55.  2007
  58. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.
    Authors: Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, Jones SA, Rose-John S, Scheller J
    Blood, 2007;111(3):1021-8.  2007
  59. Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes.
    Authors: Arias MA, Jaramillo G, Lopez YP, Mejia N, Mejia C, Pantoja AE, Shattock RJ, Garcia LF, Griffin GE
    J. Immunol., 2007;179(12):8381-91.  2007
  60. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report.
    Authors: Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM
    Chest, 2007;132(1):58-63.  2007
  61. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells.
    Authors: Infantino S, Moepps B, Thelen M
    J. Immunol., 2006;176(4):2197-207.  2006
  62. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
    Authors: Wang J, Wu G, Manick B, Hernandez V, Renelt M, Erickson C, Guan J, Singh R, Rollins S, Solorz A, Bi M, Li J, Grabowski D, Dirkx J, Tracy C, Stuart T, Ellinghuysen C, Desmond D, Foster C, Kalabokis V
    Immunology, 0;156(1):74-85.  0

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs

Supplemental ELISA Products

ELISA Plate Sealers

DY992
2 Citations
8 Reviews
1 Image
ELISA

Reagent Diluent Concentrate 2

DY995
25 Citations
19 Reviews
1 Image
ELISA

Stop Solution 2N Sulfuric Acid

DY994
20 Citations
17 Reviews
1 Image
ELISA

Glo Substrate Reagent Pack

DY993
4 Citations
2 Reviews
1 Image
ELISA

Cell Lysis Buffer 3 Concentrate (5X, 1 x 21 mL)

895366
2 Reviews
ELISA

Reagent Diluent Concentrate 3 (5X)

DY004
2 Reviews
1 Image
ELISA

Reagent Additive 1

DY005
2 Citations
4 Reviews
1 Image
ELISA

Quantikine ELISA Wash Buffer 1

WA126
8 Citations
5 Reviews
1 Image
ELISA

Sample Diluent Concentrate 1 (5X)

DYC001
3 Citations
3 Reviews
1 Image
ELISA

Cell Lysis Buffer 2

895347
4 Citations
3 Reviews
1 Image
ELISA

Cell Lysis Buffer 5 (1 x 21 mL)

895890
1 Citations
ELISA

Cell Lysis Buffer 1 (1 x 21 mL)

890713
2 Citations
2 Reviews
ELISA

Clear Polystyrene Microplates

DY990
5 Citations
13 Reviews
1 Image
ELISA

Sample Diluent Concentrate 2 (2X)

DYC002
3 Citations
2 Reviews
1 Image
ELISA

Reagent Diluent Concentrate 1

DY997
2 Citations
2 Reviews
1 Image
ELISA

Substrate Reagent Pack

DY999
82 Citations
37 Reviews
1 Image
ELISA

Black Polystyrene Microplates, 25 Pack

DY991
2 Citations
ELISA

Reviews for Streptavidin-HRP

Average Rating: 4.8 (Based on 13 Reviews)

5 Star
76.92%
4 Star
23.08%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Streptavidin-HRP?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Streptavidin-HRP
By Anonymous on 02/26/2020
Application:

Used Strep-HRP to develop an IL-25 ELISA.
Works as expected at the suggested concentration.
Very nice results, standards and control show up nicely.

Serum Streptavidin-HRP DY998
Streptavidin-HRP
By Anonymous on 01/22/2020
Application:

1:200 dilution in 1% milk used for wesern blot of biotinylated viral protein.
15% gel, wet transfer, overnight incubation with Streptavidin-HRP.
Only specific bands were seen and no background at all.
Highly recommended

Serum Streptavidin-HRP DY998
Streptavidin-HRP
By Anonymous on 11/06/2019
Application:
Serum Streptavidin-HRP DY998
Streptavidin-HRP
By Anonymous on 03/29/2019
Application:

Used SA-HRP 1:200 for 30 min to compared a in-house biotinylated antibody to the unconjugated with direct ELISA

Serum Streptavidin-HRP DY998
Streptavidin-HRP
By Anonymous on 11/26/2018
Application:
Streptavidin-HRP
By Anonymous on 11/06/2018
Application:
Streptavidin-HRP
By Anonymous on 08/17/2018
Application:
Streptavidin-HRP
By Anonymous on 04/16/2018
Application:

We used this Ab for the Elisa in a 1:200 dilution, it works very well, showed no background.

Streptavidin-HRP
By Anonymous on 12/18/2017
Application:
Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 12/05/2017
Application:
Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 07/20/2017
Application:

Standard ELISA protocol observed for concentration analysis

Serum Streptavidin-HRP (set of 5 vials enough for 75 plates total) DY998
Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 12/21/2016
Application:

Western blot of biotinated molecule.1:1000dilution of the product in BSA

Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 06/02/2016
Application: